Data / Form D filings / Vetmab Biosciences, Inc.
Vetmab Biosciences, Inc.: Form D filings
Vetmab Biosciences, Inc., a biotechnology company in San Diego, CA, filed 6 Form D notices with the SEC between 2022 and 2026. The latest, on September 29, 2026, reports $11.4 million sold of a $11.9 million offering to 30 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3445 MIDWAY DRIVE, SUITE E #292, San Diego, CA, 92110
- Phone
- (619) 723-6476
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1932050
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | New notice | $11,944,990 | $11,439,990 | $505,000 | 30 | Sep 17, 2026 | sec.gov |
| Dec 5, 2023 | Amendment | $5,000,000 | $575,000 | $4,425,000 | 5 | Nov 21, 2023 | sec.gov |
| Dec 5, 2023 | New notice | $5,000,000 | $575,000 | $4,425,000 | 5 | Nov 21, 2023 | sec.gov |
| Aug 22, 2022 | New notice | $2,000,000 | $2,000,000 | 28 | Aug 9, 2022 | sec.gov | |
| Jul 19, 2022 | Amendment | $22 | $22 | 42 | Jul 8, 2022 | sec.gov | |
| Jun 10, 2022 | New notice | $22 | $22 | 42 | May 15, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Denise Bevers | Executive Officer, Director | |
| Richard Chin | Executive Officer, Director | |
| Hangjun Zhan | Director | |
| Neeraj Agrawal | Director | |
| Chrysa Mineo | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 28, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vetmab Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.